Matches in Wikidata for { <http://www.wikidata.org/entity/Q92866893> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q92866893 description "article scientifique publié en 2019" @default.
- Q92866893 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92866893 description "scientific article published on 26 August 2019" @default.
- Q92866893 description "wetenschappelijk artikel" @default.
- Q92866893 description "наукова стаття, опублікована 26 серпня 2019" @default.
- Q92866893 name "No Role for Maintenance Bevacizumab for Up-Front Stage IIIc (R0) Ovarian Cancer" @default.
- Q92866893 name "No Role for Maintenance Bevacizumab for Up-Front Stage IIIc (R0) Ovarian Cancer" @default.
- Q92866893 type Item @default.
- Q92866893 label "No Role for Maintenance Bevacizumab for Up-Front Stage IIIc (R0) Ovarian Cancer" @default.
- Q92866893 label "No Role for Maintenance Bevacizumab for Up-Front Stage IIIc (R0) Ovarian Cancer" @default.
- Q92866893 prefLabel "No Role for Maintenance Bevacizumab for Up-Front Stage IIIc (R0) Ovarian Cancer" @default.
- Q92866893 prefLabel "No Role for Maintenance Bevacizumab for Up-Front Stage IIIc (R0) Ovarian Cancer" @default.
- Q92866893 P1433 Q92866893-66FAA877-D567-4836-B4EC-AEAEE1332EC5 @default.
- Q92866893 P1476 Q92866893-CBF8508C-C59F-4F23-A89B-2B89DC21AECF @default.
- Q92866893 P2093 Q92866893-2E82998D-EF82-41B4-9E5B-27194EFEE1B8 @default.
- Q92866893 P2093 Q92866893-3F0A4EA5-69D5-4C87-9BEE-352E705EAACD @default.
- Q92866893 P2093 Q92866893-4B46EB64-36DE-4C38-9C51-D69314287B4E @default.
- Q92866893 P2093 Q92866893-51F6452A-FAE9-479C-90C8-C64CE985DA8E @default.
- Q92866893 P2093 Q92866893-CAE0F9EF-C23F-4628-92CA-B824495F7D42 @default.
- Q92866893 P2093 Q92866893-CE4D479C-6419-4D19-B2E1-2D3F6E15B8BE @default.
- Q92866893 P2093 Q92866893-F80555C0-A23C-4D17-B90C-D211DA497479 @default.
- Q92866893 P304 Q92866893-02701069-51D8-448A-96FE-60B2E2A50B5A @default.
- Q92866893 P31 Q92866893-0A083A7D-E1A8-4681-9B86-77D1CBC107F7 @default.
- Q92866893 P356 Q92866893-072CCC70-8D5E-4877-BE82-B4B82DAB87AF @default.
- Q92866893 P433 Q92866893-2DBE5027-DF4B-4D6B-8DDB-7992D9216A08 @default.
- Q92866893 P478 Q92866893-C1D4E915-BC6E-4C25-A95C-E86C0858C362 @default.
- Q92866893 P577 Q92866893-872FB1D4-B0DE-499B-BC7C-4A9DC6A18720 @default.
- Q92866893 P698 Q92866893-FBBAA127-D456-49E6-8011-D1C15F775F93 @default.
- Q92866893 P921 Q92866893-921369BA-4D97-4BC8-92E0-11D93F439D30 @default.
- Q92866893 P921 Q92866893-C0F1FE82-0C15-45B6-8B84-366AE5B2DE9A @default.
- Q92866893 P356 JCO.19.01650 @default.
- Q92866893 P698 31449471 @default.
- Q92866893 P1433 Q400292 @default.
- Q92866893 P1476 "No Role for Maintenance Bevacizumab for Up-Front Stage IIIc (R0) Ovarian Cancer" @default.
- Q92866893 P2093 "Alexander B Olawaiye" @default.
- Q92866893 P2093 "Charles N Landen" @default.
- Q92866893 P2093 "Gordon Rustin" @default.
- Q92866893 P2093 "Jessica L Berger" @default.
- Q92866893 P2093 "Joseph L Kelley" @default.
- Q92866893 P2093 "Ronald J Buckanovich" @default.
- Q92866893 P2093 "Shitanshu Uppal" @default.
- Q92866893 P304 "2707-2708" @default.
- Q92866893 P31 Q13442814 @default.
- Q92866893 P356 "10.1200/JCO.19.01650" @default.
- Q92866893 P433 "29" @default.
- Q92866893 P478 "37" @default.
- Q92866893 P577 "2019-08-26T00:00:00Z" @default.
- Q92866893 P698 "31449471" @default.
- Q92866893 P921 Q172341 @default.
- Q92866893 P921 Q413299 @default.